Related Experiment Video
Updated: Jul 19, 2026
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
The pathogenetic aspects and gene polymorphisms of IgA nephropathy
D Maixnerová1, M Merta, J Reiterová
1Department of Nephrology of the First Faculty of Medicine, Charles University and General Teaching Hospital, U Nemocnice 2, 128 08 Prague 2, Czech Republic. dkment@centrum.cz
Prague Medical Report
|October 28, 2006
Summary
Immunoglobulin A nephropathy (IgAN) involves IgA deposits in the kidneys, often presenting with hematuria. Understanding its complex causes, including genetic and environmental factors, is key to developing new treatments.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Immunoglobulin A nephropathy (IgAN) is an immune-complex-mediated glomerulonephritis.
- Characterized by mesangial deposition of IgA-containing immune complexes.
- Clinical presentation varies from microscopic hematuria to end-stage renal disease.
Purpose of the Study:
- To summarize the understanding of IgA nephropathy pathogenesis.
- To highlight the multifactorial nature of IgAN.
- To emphasize the need for further research into therapeutic possibilities.
Main Methods:
- Review of existing literature on IgA nephropathy.
- Analysis of pathogenetic mechanisms.
- Discussion of clinical presentations and progression factors.
Main Results:
- IgAN pathogenesis involves abnormal IgA1 O-glycosylation, genetic, and environmental factors.
- Mesangial cell response to IgA deposition is critical.
- Progression is influenced by factors like hypertension and proteinuria.
Conclusions:
- Precise pathogenetic mechanisms require further elucidation.
- Genetic predisposition is essential for IgA deposition to trigger glomerulonephritis.
- Development of novel therapeutic strategies is needed.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...